Drugs / AMSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03827096 | Aug 2013 → Dec 2016 | intervertebral disk degenerative disorder | Bioinova, s.r.o. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMSC | “Suspension of the cultured AMSC will then be sterilely packed and transported to the surgery site.” NCT03827096 ↗ |
| Modality | Cell therapy | “receiving autologous multipotent mesenchymal stem cells” NCT03827096 ↗ |
| Route | Other | “inserted between the transverse processes of the lumbar spine” NCT03827096 ↗ |